Author

Ziwei Zhang

Dana-Farber Cancer InstituteORCID 0000-0002-5705-4611Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ziwei Zhang3 papers · University of Cambridge

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

Adrian Francis StewartiD· 1 shared Amin H. NassariD· 1 shared Andrea KranziD· 1 shared Annabelle WurmseriD· 1 shared Atef Mir AliiD· 1 shared Berthold GöttgensiD· 1 shared Brad J. FortunatoiD· 1 shared Brian J.P. HuntlyiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Adrian Francis StewartORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-catalytic role for MLL2 in controlling chromatin organisation and mobility during priming of pluripotent cells for differentiation

M. Steindel, Oliver Davis, Katrin Neumann, Gökçe G. Agsu, Lingjun Mao, Andrea Kranz, Liviu Pirvan, Dwaipayan Adhya, Jörg Morf, Ziwei Zhang, Shuyue Yang, Jun Fu, Melania Barile, Annabelle Wurmser, Stanley E. Strawbridge, , Srinjan Basu

This study shows MLL2 stabilizes 3D chromatin loops during pluripotent cell differentiation without requiring its enzymatic activity.

bioRxiv · Feb 21, 2025 · PreprintCell Biology

Epigenomic signatures as circulating and predictive biomarkers in sarcomatoid renal cell carcinoma

Talal El Zarif, Karl Semaan, Marc Eid, Ji-Heui Seo, Simon Garinet, Matthew P. Davidsohn, Pranshu Sahgal, Brad J. Fortunato, John Canniff, Amin H. Nassar, Sarah Abou Alaiwi, Ziad Bakouny, Gitanjali Lakshminarayanan, Hunter Savignano, Kevin Lyons, , Sylvan C. Baca

The paper identifies epigenomic signatures in sarcomatoid renal cell carcinoma (sRCC) that predict response to immune checkpoint inhibitors and are detectable in plasma, enabling non-invasive diagnosis.

Cell Reports · Jun 1, 2024Peer-reviewedGenomics